Skip to main content

Table 1 Comparison of measures of brain atrophy between multiple sclerosis (MS) patients’ and control groups

From: Validation of brain parenchyma sonography as a marker of neurodegeneration in multiple sclerosis

 

MS group

(n = 48)

Control group

(n = 57)

p- value

Range

Mean ± SD

Range

Mean ± SD

Ventricular

diameter (cm)

3rd ventricle

0.12–0.76

0.34 ± 0.15

0.07–0.45

0.2 ± 0.08

< 0.001*

Rt. FH

0.3–0.87

0.49 ± 0.14

0.12–0.85

0.30 ± 0.13

< 0.001*

Lt. FH

0.23–0.92

0.45 ± 0.15

0.02–0.54

0.28 ± 0.1

< 0.001*

SA of DGM (cm2)

Rt. Th

2.11–7.78

4.18 ± 1.1

2.59–6.88

4.43 ± 0.97

0.22

Lt. Th

1.87–7.8

4.29 ± 1.27

2.48–8.55

4.67 ± 1.24

0.12

Rt. SN

0.02–0.95

0.19 ± 0.13

0.03–0.26

0.15 ± 0.05

0.04*

Lt. SN

0.05–0.34

0.17 ± 0.07

0.05–0.26

0.15 ± 0.06

0.17

Rt. RN

0.04–0.46

0.08 ± 0.07

0.02–0.17

0.05 ± 0.03

0.01*

Lt. RN

0.02–0.6

0.09 ± 0.08

0.01–0.16

0.06 ± 0.03

0.04*

  1. TCS transcranial sonography, MS multiple sclerosis, n number, 3rd third, cm centimeters, Rt. right, Lt. left, FH frontal horn, SA surface area, DGM deep grey matter, cm2 centimeter square, Th thalamus, SN substantia nigra, RN red nucleus